Cleared Special

K201178 - iLab Polaris Multi-Modality Guidance Sy...

K201178 is the FDA 510(k) clearance for iLab Polaris Multi-Modality Guidance Sy... by Boston Scientific. It is a Class 2 Cardiovascular device (product code DQK) cleared through the Special 510(k) pathway after a 28-day FDA review.

K201178 · Boston Scientific · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
28d
Days
Class 2
Risk

K201178 is an FDA 510(k) clearance for the iLab Polaris Multi-Modality Guidance System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Boston Scientific (Maple Grove, US). The FDA issued a Cleared decision on May 29, 2020 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific devices

Submission Details

510(k) Number K201178 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 2020
Decision Date May 29, 2020
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 246
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K201178.
AVVIGO Guidance System
K201713 · Boston Scientific Corporation · Jul 2020
EnSite Precision Cardiac Mapping System v2.6, EnSite Precision Software Installation v2.6, EnSite LiveView Dynamic Display Software License
K201148 · Abbott Medical · Jun 2020
EnSite Velocity Cardiac Mapping System, EnSite Precision Cardiac Mapping System
K201181 · Abbott Medical · Jun 2020
AcQMap High Resolution Imaging and Mapping System
K193013 · Acutus Medical, Inc. · Feb 2020
Rhythmia HDxTM Mapping System
K192438 · Boston Scientific Corporation · Nov 2019
AcQMap High Resolution Imaging and Mapping System
K191392 · Acutus Medical, Inc. · Sep 2019